Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence. / Kofoed, Steen C; Calatayud, Dan; Jensen, Lone S; Helgstrand, Frederik; Achiam, Michael P; De Heer, Pieter; Svendsen, Lars B; Danish Esophageal, Cardia and Stomach Cancer Group.

I: Journal of Thoracic and Cardiovascular Surgery, Bind 150, Nr. 1, 07.2015, s. 42-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kofoed, SC, Calatayud, D, Jensen, LS, Helgstrand, F, Achiam, MP, De Heer, P, Svendsen, LB & Danish Esophageal, Cardia and Stomach Cancer Group 2015, 'Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence', Journal of Thoracic and Cardiovascular Surgery, bind 150, nr. 1, s. 42-8. https://doi.org/10.1016/j.jtcvs.2015.04.030

APA

Kofoed, S. C., Calatayud, D., Jensen, L. S., Helgstrand, F., Achiam, M. P., De Heer, P., Svendsen, L. B., & Danish Esophageal, Cardia and Stomach Cancer Group (2015). Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence. Journal of Thoracic and Cardiovascular Surgery, 150(1), 42-8. https://doi.org/10.1016/j.jtcvs.2015.04.030

Vancouver

Kofoed SC, Calatayud D, Jensen LS, Helgstrand F, Achiam MP, De Heer P o.a. Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence. Journal of Thoracic and Cardiovascular Surgery. 2015 jul.;150(1):42-8. https://doi.org/10.1016/j.jtcvs.2015.04.030

Author

Kofoed, Steen C ; Calatayud, Dan ; Jensen, Lone S ; Helgstrand, Frederik ; Achiam, Michael P ; De Heer, Pieter ; Svendsen, Lars B ; Danish Esophageal, Cardia and Stomach Cancer Group. / Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence. I: Journal of Thoracic and Cardiovascular Surgery. 2015 ; Bind 150, Nr. 1. s. 42-8.

Bibtex

@article{742af1e92e744da68876772c82aa54f4,
title = "Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence",
abstract = "OBJECTIVE: Intrathoracic anastomotic leakage after intended curative resection for cancer in the esophagus or gastroesophageal junction has a negative impact on long-term survival. The aim of this study was to investigate whether an anastomotic leakage was associated with an increased recurrence rate.METHODS: This nationwide study included consecutively collected data on patients undergoing curative surgical resection with intrathoracic anastomosis, alive 8 weeks postoperatively, between 2003 and 2011. Patients with incomplete resection, or metastatic disease intraoperatively, were excluded. Only biopsy-proven recurrences were accepted.RESULTS: In total, 1085 patients were included. The frequency of anastomotic leakage was 8.6%. The median follow-up time was 29 months (interquartile range [IQR]: 13-58 months). Overall, 369 (34%) patients had disease recurrence, of which 346 patients died of recurrent gastroesophageal carcinoma. Twenty-three patients were alive with recurrence at the censoring date. In the study period, 333 patients died without signs of recurrent disease. The overall median time to recurrence was 66 weeks (IQR: 38-109 weeks). Distant metastases were found in 267 (25%), and local disease recurrence in 102 (9%) patients. Overall, 5-year disease-free survival in patients with leakage was 27%, versus 39% in those without leakage (P = .017). Anastomotic leakage was independently associated with higher risk of recurrence (hazard ratio [HR] = 1.63; 95% confidence interval [CI]: 1.17-2.29, P = .004) and all-cause mortality (HR = 1.57; 95% CI: 1.23-2.05, P < .0001).CONCLUSIONS: Intrathoracic anastomotic leakage increased the risk of recurrence in patients who underwent curative gastroesophageal cancer resection.",
keywords = "Anastomotic Leak, Esophageal Neoplasms, Esophagogastric Junction, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Prospective Studies, Risk Assessment, Stomach Neoplasms, Thorax",
author = "Kofoed, {Steen C} and Dan Calatayud and Jensen, {Lone S} and Frederik Helgstrand and Achiam, {Michael P} and {De Heer}, Pieter and Svendsen, {Lars B} and {Danish Esophageal, Cardia and Stomach Cancer Group}",
note = "Copyright {\textcopyright} 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.",
year = "2015",
month = jul,
doi = "10.1016/j.jtcvs.2015.04.030",
language = "English",
volume = "150",
pages = "42--8",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Intrathoracic anastomotic leakage after gastroesophageal cancer resection is associated with increased risk of recurrence

AU - Kofoed, Steen C

AU - Calatayud, Dan

AU - Jensen, Lone S

AU - Helgstrand, Frederik

AU - Achiam, Michael P

AU - De Heer, Pieter

AU - Svendsen, Lars B

AU - Danish Esophageal, Cardia and Stomach Cancer Group

N1 - Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

PY - 2015/7

Y1 - 2015/7

N2 - OBJECTIVE: Intrathoracic anastomotic leakage after intended curative resection for cancer in the esophagus or gastroesophageal junction has a negative impact on long-term survival. The aim of this study was to investigate whether an anastomotic leakage was associated with an increased recurrence rate.METHODS: This nationwide study included consecutively collected data on patients undergoing curative surgical resection with intrathoracic anastomosis, alive 8 weeks postoperatively, between 2003 and 2011. Patients with incomplete resection, or metastatic disease intraoperatively, were excluded. Only biopsy-proven recurrences were accepted.RESULTS: In total, 1085 patients were included. The frequency of anastomotic leakage was 8.6%. The median follow-up time was 29 months (interquartile range [IQR]: 13-58 months). Overall, 369 (34%) patients had disease recurrence, of which 346 patients died of recurrent gastroesophageal carcinoma. Twenty-three patients were alive with recurrence at the censoring date. In the study period, 333 patients died without signs of recurrent disease. The overall median time to recurrence was 66 weeks (IQR: 38-109 weeks). Distant metastases were found in 267 (25%), and local disease recurrence in 102 (9%) patients. Overall, 5-year disease-free survival in patients with leakage was 27%, versus 39% in those without leakage (P = .017). Anastomotic leakage was independently associated with higher risk of recurrence (hazard ratio [HR] = 1.63; 95% confidence interval [CI]: 1.17-2.29, P = .004) and all-cause mortality (HR = 1.57; 95% CI: 1.23-2.05, P < .0001).CONCLUSIONS: Intrathoracic anastomotic leakage increased the risk of recurrence in patients who underwent curative gastroesophageal cancer resection.

AB - OBJECTIVE: Intrathoracic anastomotic leakage after intended curative resection for cancer in the esophagus or gastroesophageal junction has a negative impact on long-term survival. The aim of this study was to investigate whether an anastomotic leakage was associated with an increased recurrence rate.METHODS: This nationwide study included consecutively collected data on patients undergoing curative surgical resection with intrathoracic anastomosis, alive 8 weeks postoperatively, between 2003 and 2011. Patients with incomplete resection, or metastatic disease intraoperatively, were excluded. Only biopsy-proven recurrences were accepted.RESULTS: In total, 1085 patients were included. The frequency of anastomotic leakage was 8.6%. The median follow-up time was 29 months (interquartile range [IQR]: 13-58 months). Overall, 369 (34%) patients had disease recurrence, of which 346 patients died of recurrent gastroesophageal carcinoma. Twenty-three patients were alive with recurrence at the censoring date. In the study period, 333 patients died without signs of recurrent disease. The overall median time to recurrence was 66 weeks (IQR: 38-109 weeks). Distant metastases were found in 267 (25%), and local disease recurrence in 102 (9%) patients. Overall, 5-year disease-free survival in patients with leakage was 27%, versus 39% in those without leakage (P = .017). Anastomotic leakage was independently associated with higher risk of recurrence (hazard ratio [HR] = 1.63; 95% confidence interval [CI]: 1.17-2.29, P = .004) and all-cause mortality (HR = 1.57; 95% CI: 1.23-2.05, P < .0001).CONCLUSIONS: Intrathoracic anastomotic leakage increased the risk of recurrence in patients who underwent curative gastroesophageal cancer resection.

KW - Anastomotic Leak

KW - Esophageal Neoplasms

KW - Esophagogastric Junction

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Prospective Studies

KW - Risk Assessment

KW - Stomach Neoplasms

KW - Thorax

U2 - 10.1016/j.jtcvs.2015.04.030

DO - 10.1016/j.jtcvs.2015.04.030

M3 - Journal article

C2 - 25986493

VL - 150

SP - 42

EP - 48

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -

ID: 160448416